Loading company…
Hod HaSharon-based Medial EarlySign uses an AI platform to flag warning signals and health risks in patients with serious conditions.
Founded in 2013 and based in Hod HaSharon, Israel, Medial Research Ltd., operating as Medial EarlySign, offers an AI-based platform that detects warning signals and health risks for patients with life-altering medical conditions. In March 2018, aMoon led a USD 30 million Series B round, with participation from Horizons Ventures and the company's management.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in